[go: up one dir, main page]

FR2621817B1 - Medicament comprenant l'association de polymyxine b, de tobramycine et d'amphotericine b administre par vaporisation - Google Patents

Medicament comprenant l'association de polymyxine b, de tobramycine et d'amphotericine b administre par vaporisation

Info

Publication number
FR2621817B1
FR2621817B1 FR8714345A FR8714345A FR2621817B1 FR 2621817 B1 FR2621817 B1 FR 2621817B1 FR 8714345 A FR8714345 A FR 8714345A FR 8714345 A FR8714345 A FR 8714345A FR 2621817 B1 FR2621817 B1 FR 2621817B1
Authority
FR
France
Prior art keywords
polymyxin
tobramycin
amphotericin
vaporized
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR8714345A
Other languages
English (en)
Other versions
FR2621817A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medipro
Original Assignee
Medipro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medipro filed Critical Medipro
Priority to FR8714345A priority Critical patent/FR2621817B1/fr
Priority to EP19880909559 priority patent/EP0338062A1/fr
Priority to AU26140/88A priority patent/AU2614088A/en
Priority to PCT/FR1988/000513 priority patent/WO1989003673A1/fr
Publication of FR2621817A1 publication Critical patent/FR2621817A1/fr
Application granted granted Critical
Publication of FR2621817B1 publication Critical patent/FR2621817B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
FR8714345A 1987-10-19 1987-10-19 Medicament comprenant l'association de polymyxine b, de tobramycine et d'amphotericine b administre par vaporisation Expired - Lifetime FR2621817B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR8714345A FR2621817B1 (fr) 1987-10-19 1987-10-19 Medicament comprenant l'association de polymyxine b, de tobramycine et d'amphotericine b administre par vaporisation
EP19880909559 EP0338062A1 (fr) 1987-10-19 1988-10-19 Medicament comprenant l'association de polymyxine b, de tobramycine et d'amphotericine b administre par vaporisation
AU26140/88A AU2614088A (en) 1987-10-19 1988-10-19 Drug comprising the association of polymyxin b, tobramycin and amphotericin b administered by spraying
PCT/FR1988/000513 WO1989003673A1 (fr) 1987-10-19 1988-10-19 Medicament comprenant l'association de polymyxine b, de tobramycine et d'amphotericine b administre par vaporisation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8714345A FR2621817B1 (fr) 1987-10-19 1987-10-19 Medicament comprenant l'association de polymyxine b, de tobramycine et d'amphotericine b administre par vaporisation

Publications (2)

Publication Number Publication Date
FR2621817A1 FR2621817A1 (fr) 1989-04-21
FR2621817B1 true FR2621817B1 (fr) 1990-12-14

Family

ID=9355910

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8714345A Expired - Lifetime FR2621817B1 (fr) 1987-10-19 1987-10-19 Medicament comprenant l'association de polymyxine b, de tobramycine et d'amphotericine b administre par vaporisation

Country Status (4)

Country Link
EP (1) EP0338062A1 (fr)
AU (1) AU2614088A (fr)
FR (1) FR2621817B1 (fr)
WO (1) WO1989003673A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2290707A (en) * 1994-06-28 1996-01-10 Georgi Stankov Pharmaceutical uses of Amphotericin B
GB2290708A (en) * 1994-06-28 1996-01-10 Georgi Stankov Pharmaceutical uses of polyene macrolides
EP2077132A1 (fr) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispositif distributeur, dispositif de stockage et procédé pour la distribution d'une formulation
US10011906B2 (en) 2009-03-31 2018-07-03 Beohringer Ingelheim International Gmbh Method for coating a surface of a component
JP5763053B2 (ja) 2009-05-18 2015-08-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング アダプタ、吸入器具及びアトマイザ
EP2504051B1 (fr) 2009-11-25 2019-09-04 Boehringer Ingelheim International GmbH Nébuliseur
AP3141A (en) 2009-11-25 2015-02-28 Boehringer Ingelheim Int Nebulizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
JP5874724B2 (ja) 2010-06-24 2016-03-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
WO2012130757A1 (fr) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Appareil médical pourvu d'un récipient
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (fr) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Pulvérisateur comprenant des moyens de détrompage
ES2836977T3 (es) 2013-08-09 2021-06-28 Boehringer Ingelheim Int Nebulizador
US9744313B2 (en) 2013-08-09 2017-08-29 Boehringer Ingelheim International Gmbh Nebulizer
CN106255554B (zh) 2014-05-07 2021-05-04 勃林格殷格翰国际有限公司 容器、喷雾器及用途
PE20210959A1 (es) 2014-05-07 2021-05-25 Boehringer Ingelheim Int Nebulizador, dispositivo indicador y recipiente
ES2874029T3 (es) 2014-05-07 2021-11-04 Boehringer Ingelheim Int Nebulizador
WO2025137891A1 (fr) * 2023-12-26 2025-07-03 苏州大学 Utilisation d'un médicament à composés associés dans le traitement d'une infection persistante par des bactéries pathogènes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL121455C (fr) * 1900-01-01
BE629985A (fr) * 1962-11-29
AU539563B2 (en) * 1981-01-21 1984-10-04 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Primycin, doxycyline and sisomicin composition

Also Published As

Publication number Publication date
WO1989003673A1 (fr) 1989-05-05
EP0338062A1 (fr) 1989-10-25
AU2614088A (en) 1989-05-23
FR2621817A1 (fr) 1989-04-21

Similar Documents

Publication Publication Date Title
FR2621817B1 (fr) Medicament comprenant l'association de polymyxine b, de tobramycine et d'amphotericine b administre par vaporisation
FR2624015B1 (fr) Medicament comprenant l'association de colistine, de tobramycine et d'amphotericine b administre par vaporisation
MX9203808A (es) Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
FR2621818B1 (fr) Medicament comprenant l'association de polymixine b, de netilmicine et d'amphotericine b administre par vaporisation
GR3017686T3 (en) Fluorocytidine derivatives, their preparation and medical preparations containing them.
GB2215986B (en) Disposable absorbent garments.
MX9203504A (es) Complejo agente: lipido activo de alta proporcion.
DE3880593D1 (de) Arzneizubereitungen mit retardierter wirkstofffreisetzung.
FI943512L (fi) Ihmisen seerumialbumiini, valmistus ja käyttö
DE3882157D1 (de) Nichtsteroide antientzuendungswirkstoffe enthaltende pharmazeutische zubereitungen.
FR2667317B1 (fr) Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
ATA80390A (de) Pharmazeutisches präparat mit verzögerter wirkstofffreisetzung auf basis von hemicellulosen
TR199903192T2 (xx) Eritropoetin, de�i�tirilmi� hemoglobin i�eren farmasotik kombine m�stahzarlar.
DE69013557D1 (de) An Liposome gekuppelte bioaktive Verbindungen und ihre Verwendung in pharmazeutischen Zubereitungen.
DE68902300D1 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.
FR2718451B1 (fr) Dérivés de peptides boroniques, leur préparation et leur application en thérapeutique.
DE3867086D1 (de) Benzothiepino(5,4-c)pyridazin-verbindungen und ihre pharmazeutischen wirkungen.
NO167371C (no) Anordning ved stol.
NO168477C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kondenserte diazepinoner.
NO903939L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kondenserte diazepinoner.
FR2572932B1 (fr) Medicament insoluble administre localement dans l'oreille
EP0489933A4 (en) Bile alcohol and drug containing the same as active ingredient
FR2697253B1 (fr) Dérivés de 2-aminopyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique.
FR2694292B1 (fr) Dérivés de benzimidazole-2-thione-, leur préparation et leur application en tant que médicament.
FR2769629B1 (fr) Derives de 8-azabicyclo[3.2.1]octane-3-methanamine, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
ST Notification of lapse